Neurology

A doctor told Lucy Younger that her brain tumour symptoms were from “drinking too much” and being “away from home” before an “incredible” pharmacist sent her to get an MRI scan... 

The pharmacy negotiator has warned that one ADHD drug is in short supply, while some period delay and opioid dependency drugs will remain “out of stock” into the autumn.  

A manufacturer has recalled a medicine used to treat multiple sclerosis (MS) “as a precautionary measure”, the pharmacy negotiator has announced.

Tomorrow will see three hormone replacement therapy (HRT) drugs removed from the pre-payment certificate (PPC) list, while 39 batches of an ADHD drug have been recalled.  

As the amount of medication prescribed for ADHD rose by nearly 15% in 2023/24, a Labour councillor has blamed Brexit for shortages of medicines to treat the condition.

The DH has announced that a medication for attention deficit hyperactivity disorder (ADHD) is out of stock until next month amid ongoing shortages of drugs to treat the condition.

The medicines watchdog is finalising a review of asthma drug montelukast after a rise in Yellow Card reports, amid a shortage of other asthma drugs. 

Children born to men on valproate are more likely to develop neurodevelopmental disorders, the medicines watchdog has warned.

The Department of Health and Social Care (DH) and the Medicines and Healthcare products Regulatory Agency (MHRA) have added five ADHD medications to the list of drugs that wholesalers are prevented from exporting or hoarding. 

A Department of Health and Social Care (DH) patient safety alert has warned pharmacies that “safety critical” shortages of a plethora of ADHD drugs could last months.